Chosa ApS: Financial statements 2025
CVR: 43134477
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Chosa ApS (CVR 43134477) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -2,136,143 and a net result of DKK -2,632,024 compared with DKK -3,586,839 the year before. Equity in the 2025 report amounted to DKK 5,175,030. The solvency ratio was 38.5%.
- Gross Profit
- DKK -2,136,143
- Profit/Loss
- DKK -2,632,024
- Equity
- DKK 5,175,030
- Total Assets
- DKK 13,427,118
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -2.1 mio. | -2.6 mio. | 5.2 mio. | 0 |
| 2024 | - | -1.1 mio. | -3.6 mio. | 7.5 mio. | 1 |
| 2023 | - | -1.5 mio. | -2.1 mio. | 9 mio. | 0 |
Official annual report
How creditworthy is Chosa ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of November 25, 2025, Neil Goldsmith has stepped down as director of Chosa ApS.
Chosa ApS has published its annual report for 2024. Gross profit came to DKK -1,130,610, and the net result was DKK -3,586,839.
About Chosa ApS
Chosa ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2022. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Peter Buhl and Claus Frisenberg Pedersen. The company is owned by Chosa Oncology AB. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -2,136,143 and a net result of DKK -2,632,024 compared with DKK -3,586,839 the year before. Equity in the 2025 report amounted to DKK 5,175,030.